CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing ...

A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula business. A deal for nutrition and Mead Johnson could potentially materialise ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

The majority of Reckitt’s portfolio is well positioned in categories that benefit from secular growth drivers across consumer health and hygiene. The acquisition of Mead Johnson has added to its ...

The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...

Reckitt and rival Abbott Laboratories are defending more than 1,000 lawsuits alleging a connection between their milk-based ...

Investing.com - Reckitt Benckiser (LON: RKT) stock retreated Friday amid uncertainty over its liabilities surrounding its ...

(Sharecast News) - Consumer goods maker Reckitt unveiled plans for a reorganisation of its divisions and said it was looking at opportunities for Mead Johnson Nutrition after a mixed 2024 as ...

On Wednesday, Reckitt said its operating profit fell 4.2 per cent to £2.43billion last year, while revenue fell 3 per cent to ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...